Literature DB >> 8666427

Gene expression of interleukin-2 in purified human peripheral blood eosinophils.

M Bossé1, M Audette, C Ferland, G Pelletier, H W Chu, A Dakhama, S Lavigne, L P Boulet, M Laviolette.   

Abstract

To verify the hypothesis that eosinophils produce interleukin-2 (IL-2), a cytokine essential for lymphocyte activation, the expression of IL-2 was examined in peripheral blood eosinophils obtained from normal, atopic, asthmatic and hypereosinophilic subjects. Purified blood cell preparations were > 95% eosinophils, the remaining cells being neutrophils. Based on morphological observations and on CD3 expression, no lymphocytes were detected in these eosinophil preparations. The expression of IL-2 mRNA was detected by reverse transcriptase polymerase chain reaction (RT-PCR) in total RNA extracted from purified eosinophils stimulated with granulocyte-macrophage colony-stimulating factor (GM-CSF), with or without calcium ionophore (A23187). In-cell RT-PCR combined with in situ hybridization further confirmed that it was the eosinophils that expressed IL-2 mRNA. Moreover, in this experiment IL-2 mRNA expression increased upon costimulation with A23187 and GM-CSF suggesting that a steady-state level of IL-2 mRNA was inducible. Finally, IL-2 was detected in purified eosinophils by immunochemistry. These data, obtained by different techniques, demonstrate that eosinophils can express IL-2. An IL-2-mediated eosinophil-lymphocyte interaction could contribute to the chronic state of cell activation in inflamed tissues where these cells are implicated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666427      PMCID: PMC1383981     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma.

Authors:  M Azzawi; B Bradley; P K Jeffery; A J Frew; A J Wardlaw; G Knowles; B Assoufi; J V Collins; S Durham; A B Kay
Journal:  Am Rev Respir Dis       Date:  1990-12

2.  Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor.

Authors:  D S Silberstein; W F Owen; J C Gasson; J F DiPersio; D W Golde; J C Bina; R Soberman; K F Austen; J R David
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein.

Authors:  P C Tai; C J Spry; C Peterson; P Venge; I Olsson
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

5.  Amplification and detection of lentiviral DNA inside cells.

Authors:  A T Haase; E F Retzel; K A Staskus
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 6.  The eosinophil and the pathophysiology of asthma.

Authors:  E Frigas; G J Gleich
Journal:  J Allergy Clin Immunol       Date:  1986-04       Impact factor: 10.793

7.  Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.

Authors:  W F Owen; M E Rothenberg; D S Silberstein; J C Gasson; R L Stevens; K F Austen; R J Soberman
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

8.  Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120.

Authors:  D R Lucey; D I Dorsky; A Nicholson-Weller; P F Weller
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

9.  Human eosinophils express transforming growth factor alpha.

Authors:  D T Wong; P F Weller; S J Galli; A Elovic; T H Rand; G T Gallagher; T Chiang; M Y Chou; K Matossian; J McBride
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

10.  Recombinant human interleukin 5 is a selective activator of human eosinophil function.

Authors:  A F Lopez; C J Sanderson; J R Gamble; H D Campbell; I G Young; M A Vadas
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  6 in total

1.  Identification of interleukin-2 in human peripheral blood eosinophils.

Authors:  F Levi-Schaffer; J Barkans; T M Newman; S Ying; M Wakelin; R Hohenstein; V Barak; P Lacy; A B Kay; R Moqbel
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

2.  Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes.

Authors:  G Woerly; N Roger; S Loiseau; D Dombrowicz; A Capron; M Capron
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

Review 3.  Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity.

Authors:  Francis Davoine; Paige Lacy
Journal:  Front Immunol       Date:  2014-11-10       Impact factor: 7.561

4.  Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study.

Authors:  Anli Yang; Zhiyong Guo; Qingqi Ren; Linwei Wu; Yi Ma; Anbin Hu; Dongping Wang; Haidan Ye; Xiaofeng Zhu; Weiqiang Ju; Xiaoshun He
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

5.  Eosinophils in human oral squamous carcinoma; role of prostaglandin D2.

Authors:  Francis Davoine; Adrian Sim; Charlie Tang; Sibina Fisher; Caroline Ethier; Lakshmi Puttagunta; Yingqi Wu; W Tim McGaw; Donald Yu; Lisa Cameron; Darryl J Adamko; Redwan Moqbel
Journal:  J Inflamm (Lond)       Date:  2013-01-31       Impact factor: 4.981

6.  Evaluation of myeloid cells (tumor-associated tissue eosinophils and mast cells) infiltration in different grades of oral squamous cell carcinoma.

Authors:  Priyanka Debta; Fakir Mohan Debta; Minal Chaudhary; Smita Bussari
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.